Cosentyx is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to treat adults 18 and older who have active psoriatic arthritis or moderate to severe plaque psoriasis. Cosentyx is also known by its drug name, secukinumab.
Cosentyx is a biologic. Cosentyx is a genetically engineered antibody, a type of protein used by the immune system to identify and neutralize substances. Cosentyx is believed to work by targeting specific proteins in the immune system and reducing inflammation.
How do I take it?
Cosentyx is injected subcutaneously once a week for the first five weeks, then once a month.
Cosentyx comes as a single-use prefilled pen or syringe.
The FDA-approved label for Cosentyx lists common side effects including cold symptoms, diarrhea, and upper respiratory tract infection.
Rare but serious side effects listed for Cosentyx include inflammatory bowel disease, hypersensitivity reactions, and severe infections including tuberculosis.
For more information about this treatment, visit:
Cosentyx — Novartis